AMMI Canada Practice Point: Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023–2024 (Q129806578): Difference between revisions
Jump to navigation
Jump to search
Created a new Item: add scholarly article from crossref (details) Tag: OpenRefine [3.8] |
(No difference)
|
Revision as of 03:12, 26 August 2024
scholarly article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AMMI Canada Practice Point: Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023–2024 |
scholarly article |
Statements
AMMI Canada Practice Point: Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023–2024 (English)
1 reference